OSE Immunotherapeutics S.A.

OSE.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents€25,394€16,745€75,746€18,672
Short-Term Investments€16,200€0€0€0
Receivables€11,676€4,138€7,554€1,805
Inventory€0€0€0€0
Other Curr. Assets€2,357€49,049€2,485€10,001
Total Curr. Assets€55,627€69,932€85,785€30,478
Property Plant & Equip (Net)€4,035€3,425€3,647€4,070
Goodwill€0€0€0€0
Intangibles€42,835€44,010€45,211€46,401
Long-Term Investments€1,493€6,400€6,084€756
Tax Assets€191€191€194€195
Other NC Assets€0€1€0€0
Total NC Assets€48,554€54,027€55,136€51,422
Other Assets€0€0€0€0
Total Assets€104,181€123,959€140,921€81,900
Liabilities
Payables€8,993€3,397€8,344€6,491
Short-Term Debt€6,180€8,389€3,921€7,261
Tax Payable€0€0€0€20
Deferred Revenue€1,377€0€2,894€347
Other Curr. Liab.€2,852€4,369€2,227€4,680
Total Curr. Liab.€19,402€20,221€17,386€18,799
LT Debt€32,484€38,338€39,964€38,540
Deferred Rev, NC€67€100€2,812€0
Deferred Tax Liab, NC€1,073€1,074€1,658€1,311
Other NC Liab.€554€415€466€429
Total NC Liab.€34,178€39,927€42,087€40,280
Other Liabilities€0€0€0€0
Cap. Leases€3,193€3,274€3,497€3,890
Total Liabilities€53,580€60,148€59,473€59,079
Equity
Pref Stock€0€0€0€155
Common Stock€4,489€4,388€4,366€4,330
Retained Earnings-€30,948-€17,871€1,046-€23,003
AOCI-€296-€293-€393-€309
Other Equity€77,356€77,295€76,429€41,803
Total Equity€50,601€63,811€81,448€22,975
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€104,181€123,959€140,921€81,900
Net Debt€13,270€29,982-€31,861€27,129